A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma
- Conditions
- Primary Open Angle Glaucoma (POAG)
- Interventions
- Device: C-Rex Instrument
- Registration Number
- NCT06615661
- Lead Sponsor
- Iantrek, Inc.
- Brief Summary
This study enrolls adults with primary open angle glaucoma (POAG) who underwent goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. Patients are consented prior to surgery and followed for 12 months postoperatively. Data regarding IOP, use of glaucoma medications, and any device-related complications are collected during the study time period.
- Detailed Description
This a multicenter, observational real-world evidence study of eligible adults with primary open angle glaucoma (POAG) in whom ab-interno goniotomy surgery with the C-Rex Instrument was performed.
Data is collected from the preoperative visit(s) that directly preceded the surgery, the surgical procedure, and post-surgical visits through 12 months postoperatively.
Specific data collected includes C-Rex Instrument goniotomy surgical details, preoperative and postoperative IOP and use of ocular hypotensive medications, and device-related safety events.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
- Primary open angle glaucoma
- Goniotomy surgery performed using the C-Rex Instrument
- History of intraocular surgery within 8 weeks prior to C-Rex surgery
- Preoperative IOP higher than 33 mmHg
- Presence of a glaucoma type other than POAG
- Presence of clinically significant intraocular pathology other than cataract or glaucoma
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description C-Rex surgery - combination C-Rex Instrument C-Rex surgery combined with cataract extraction/intraocular lens (IOL) implantation C-Rex surgery - standalone C-Rex Instrument C-Rex surgery as a standalone intervention
- Primary Outcome Measures
Name Time Method Percent of eyes with intraocular pressure (IOP)reduction ≥20%in comparison with baseline. 12 month postoperative Intraocular pressure (IOP) is at least 20% lower than before surgery without additional ocular hypotensive medications or IOP-lowering surgery.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Omni Eye Services
🇺🇸Atlanta, Georgia, United States
CIRCLE Site 04
🇺🇸Crossville, Tennessee, United States